MedPath

Exploratory Study of Respiratory Bacterial Infections or Superinfections and Colonizations in Patients With Spinal Muscular Atrophy Under NIV

Not Applicable
Completed
Conditions
Spinal Muscular Atrophy
Non Invasive Ventilation
Respiratory Bacterial Infection
Interventions
Other: non invasive ventilation samples
Other: patient samples
Other: parent questionnaire
Registration Number
NCT05712330
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

SMA (Spinal Muscular Atrophy) is a rare neuromuscular disease characterized by motoneuron damage. Symptoms consist of respiratory involvement with numerous respiratory infections and eventually respiratory failure, for which NIV (Non Invasive Ventilation) is often used. Ventilation machines are in close contact with the respiratory tract of patients. They contain heated water to humidify the circuit. These humid and warm environments are conducive to the development of bacteria such as Pseudomonas aeruginosa. In this context, it is interesting to look for the presence or absence of bacteria, in comparison with the respiratory ecology of the patients. The aim is to highlight the microbiological role of NIV on the occurrence of respiratory bacterial infections or secondary infections in patients with SMA. To do this, samples are taken from the machines, and ECBCs are performed on patients during respiratory physiotherapy sessions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Diagnosis of AMS (previous diagnosis or new diagnosis during the inclusion period)
  • Age from 0 to 12 years old
  • Nusinersen treatment
  • Benefiting from a NIV
  • Current monitoring at the University Hospital of Amiens
Exclusion Criteria
  • Invasive ventilation on tracheotomy
  • No ventilation
  • Other treatment than Nusinersen or no treatment
  • Parental refusal to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
non invasive ventilationnon invasive ventilation samplesSMA patients with NIV
non invasive ventilationpatient samplesSMA patients with NIV
non invasive ventilationparent questionnaireSMA patients with NIV
Primary Outcome Measures
NameTimeMethod
number of hospitalization days for respiratory exacerbations with germs identical to protocol samplesone year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Hospitalier Universitaire d'Amiens

🇫🇷

Amiens, Picardie, France

© Copyright 2025. All Rights Reserved by MedPath